medigraphic.com
ISSN 2448-8909 (Print)

2021, Number 3

<< Back Next >>

Med Crit 2021; 35 (3)

Ascorbic acid use in severe traumatic brain injury patients and its impact on the adult Intensive Care Unit stance

Jesús MLJD, Hernández PAE, Bravo SE, Hernández MA

Language: Spanish
References: 31
Page: 136-143
PDF size: 222.11 Kb.


ABSTRACT

Introduction: Traumatic brain injury (TBI) is the leading cause of death and disability in young adults around the world. The secondary lesion develops with the release of oxygen free radicals. In addition to its powerful action as a free radical scavenger, ascorbic acid stabilizes the endothelium and promotes the integrity of the blood-brain barrier (BBB). Objective: To determine the usefulness of ascorbic acid in patients with severe TBI and its impact on the length of hospital stay in the Adult Intensive Care Unit (ICU). Material and methods: Randomized clinical trial, open in the ICU of the Centro Médico Nacional del Bajío UMAE No. 1, León, Guanajuato, Mexico, from April 2020 to July 2020. 24 patients (12 experimental group and 12 controls) were admitted by probabilistic sampling with Severe TBI in people over 18 years of age. Administration of ascorbic acid one gram every six hours intravenously. Ascorbic acid administration was correlated with length of stay in ICU and hospitalization, mortality and neurological scales. Analysis of SPSS version 21 results. Results: 24 patients were included, mean ages 26 and 49 years, experimental and control group respectively (p = 0.004). Average of the Glasgow Coma Scale at the time of admission was 7 and 6.7 points respectively (p = 0.378). Stay in the ICU with 7 and 3.71 days (p = 0.001), hospital stay 12.5 and 5.85 days respectively (p = 0.001). At discharge, the Glasgow scale resulted in 3.50 and 3.57 points respectively (p = 0.630). 28-day mortality of 1 and 3 cases respectively (p = 0.59); the survival analysis reflected higher survival for the experimental group (p = 0.010). Conclusion: The use of ascorbic acid in severe TBI had a negative impact on the ICU stay, as well as the length of hospitalization. Survival analysis showed lower mortality at 28 days for the experimental group compared to the control.


REFERENCES

  1. Centers for Disease Control and Prevention. Surveillance report of traumatic brain injury-related emergency department visits, hospitalizations, and deaths. [Accessed November 13, 2019] https://www.cdc.gov/traumaticbraininjury/get_the_facts.html.

  2. Raúl CE, Martín MMJ. Trauma craneoencefálico. Rev Mex de Anestesiología. 2015;38:S433-S4.

  3. Guía de Práctica Clínica GPC Atención inicial de pacientes con traumatismo craneoencefálico grave en urgencias. México: Instituto Mexicano del Seguro Social; 2018.

  4. Timmons SD. Controversies in severe traumatic brain injury management. Springer, editor. Springer: Springer; 2018. p. 285.

  5. Taylor CA, Bell JM, Breiding MJ, Xu LK. Traumatic brain injury-related emergency department visits, hospitalizations, and deaths-United States, 2007 and 2013. MMWR Surveill Summ. 2017;66(9):1-18.

  6. Leichtle SW, Sarma AK, Strein M, Yajnik V, Rivet D, Sima A, et al. High-dose intravenous ascorbic acid: ready for prime time in traumatic brain injury? Neurocrit Care. 2020;32(1):333-339.

  7. SINAVE. Aspectos clínicos y epidemiológicos del trauma craneoencefálico en México 2008. [Consultada el 22 de diciembre de 2019] https://www.gob.mx/cms/uploads/attachment/file/13606/2008_sem26.pdf.

  8. Teasdale G, Maas A, Lecky F, Manley G, Stocchetti N, Murray G. The Glasgow Coma scale at 40 years: standing the test of time. Lancet Neurol. 2014;13(8):844-54.

  9. Munana-Rodríguez JE, Elías AR. Escala de coma de Glasgow: origen, análisis y uso apropiado. Enferm Univ. 2014;11(1):24-35.

  10. Carney N, Totten AM, O'Reilly C, Ullman JS, Hawryluk GWJ, Bell MJ, et al. Guidelines for the management of severe traumatic brain injury. 4th ed. Neurosurgery. 2017;80(1):6-15.

  11. Picetti E, Rossi S, Abu-Zidan FM, Ansaloni L, Armonda R, Baiocchi GL, et al. WSES consensus conference guidelines: monitoring and management of severe adult traumatic brain injury patients with polytrauma in the first 24 hours. World J Emerg Surg. 2019;14(1):53.

  12. Stocchetti N, Carbonara M, Citerio G, Ercole A, Skrifvars MB, Smielewski P, et al. Severe traumatic brain injury: targeted management in the intensive care unit. Lancet Neurol. 2017;16(6):452-464.

  13. Baratloo A, Shokravi M, Safari S, Aziz AK. Predictive value of Glasgow coma score and full outline of unresponsiveness score on the outcome of multiple trauma patients. Arch Iran Med. 2016;19(3):215-220.

  14. Brown AW, Pretz CR, Bell KR, Hammond FM, Arciniegas DB, Bodien YG, et al. Predictive utility of an adapted Marshall head CT classification scheme after traumatic brain injury. Brain Injury. 2019;33(5):610-617.

  15. Kinoshita K. Traumatic brain injury: pathophysiology for neurocritical care. J Intensive Care. 2016;4:29.

  16. Polidori MC, Mecocci P, Frei B. Plasma vitamin C levels are decreased and correlated with brain damage in patients with intracranial hemorrhage or head trauma. Stroke. 2001;32(4):898-902.

  17. Song J, Park J, Kim JH, Choi JY, Kim JY, Lee KM, et al. Dehydroascorbic acid attenuates ischemic brain edema and neurotoxicity in cerebral ischemia: an in vivo study. Exp Neurobiol. 2015;24(1):41-54.

  18. Ishaq GM, Saidu Y, Bilbis LS, Muhammad SA, Jinjir N, Shehu BB. Effects of α-tocopherol and ascorbic acid in the severity and management of traumatic brain injury in albino rats. J Neurosci Rural Pract. 2013;4(3):292-297.

  19. Winkler EA, Minter D, Yue JK, Manley GT. Cerebral edema in traumatic brain injury pathophysiology and prospective therapeutic targets. Neurosurg Clin N Am. 2016;27(4):473-488.

  20. Jain KK. The handbook of neuroprotection. 2 ed. Springer Nature: Humana Press; 2019. p. 865.

  21. Broderick JP, Adeoye O, Elm J. Evolution of the modified rankin scale and its use in future stroke trials. Stroke. 2017;48(7):2007-2012.

  22. McMillan T, Wilson L, Ponsford J, Levin H, Teasdale G, Bond M. The Glasgow outcome scale-40 years of application and refinement. Nat Rev Neurol. 2016;12(8):477-485.

  23. Yimcharoen M, Kittikunnathum S, Suknikorn C, Nak-on W, Yeethong P, Anthony TG, et al. Effects of ascorbic acid supplementation on oxidative stress markers in healthy women following a single bout of exercise. J Int Soc Sports Nut. 2019;16(1):2.

  24. Fowler AA, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12:32.

  25. May JM. Vitamin C transport and its role in the central nervous system. Sub-cellular Biochem. 2012;56:85-103.

  26. Buehner M, Pamplin J, Studer L, Hughes RL, King BT, Graybill JC, et al. Oxalate nephropathy after continuous infusion of high-dose vitamin c as an adjunct to burn resuscitation. J Burn Care Res. 2016;37(4):e374-379.

  27. Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg. 2002;236(6):814-822.

  28. Sanford K, Fisher BJ, Fowler E, Fowler AA, Natarajan R. Attenuation of red blood cell storage lesions with vitamin C. Antioxidants. 2017;6(3):55.

  29. Figueroa-Mendez R, Rivas-Arancibia S. Vitamin C in health and disease: its role in the metabolism of cells and redox state in the brain. Front Physiol. 2015;6:397.

  30. Kelly PJ, Morrow JD, Ning MM, Koroshetz W, Lo EH, Terry E, et al. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke - The biomarker evaluation for antioxidant therapies in stroke (BEAT-stroke) study. Stroke. 2008;39(1):100-104.

  31. Razmkon A, Sadidi A, Sherafat-Kazemzadeh E, Mehrafshan A, Jamali M, Malekpour B, et al. Administration of vitamin C and vitamin E in severe head injury: a randomized double-blind controlled trial. Clin Neurosurg. 2011;58:133-137.




2020     |     www.medigraphic.com